Cellerant preclinical data

In mice irradiated with lethal doses of radiation, IV allogenic mouse MP cells led to significant, dose-dependent improvements in survival when given up to 7 days post-irradiation vs. vehicle-treated controls. Furthermore, mouse MP cells mitigated death from ARS at radiation doses of up to 15 Gy. Data were published in Radiation Research. The study was supported by a 5-year grant from HHS's Biomedical Advanced Research and Development Authority (BARDA) valued at up to $170 million (see BioCentury, Sept. 19, 2011). ...